Condition

Agitation Associated With Alzheimer's Disease Dementia clinical trials and research

• 2Clinical trials
• 10Countries

All recruiting trials (2)

• EXV-802 and EXV-801 to treat agitation in Alzheimer's disease dementia

  This study will test whether two experimental medicines, EXV-802 and EXV-801, can reduce moderate-to-severe agitation in adults aged 55–90 with Alzheimer's disease dementia.

  Recruiting at 45 sites Phase 2/3 Exciva GmbH · Murrieta, California and 48 other locations · NCT07284472

• Evaluating ONO-2020 for agitation in Alzheimer's patients

  This study is testing if a new medication called ONO-2020 can help reduce agitation in people with Alzheimer's disease.

  Recruiting at 36 sites Phase 2 Ono Pharmaceutical Co., Ltd. · Aichi and 38 other locations · NCT06803823

Quick answers

How many Agitation Associated With Alzheimer's Disease Dementia clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 10 countries. The most sites are in Japan (1 trial), Canada (1 trial), Czechia (1 trial), Germany (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →